Magic mushrooms used to treat terminal cancer patients
A team of researchers from Harbor-UCLA Medical Center in Torrance, found that the drug psilocybin improved the mood of terminal cancer patients and cut their anxiety and depression. The research is believed a first step in repairing the drug’s respectability. Psilocybin is the active ingredient in “magic mushrooms”, and is classified as an illegal drug in the U.S.
In a small placebo-controlled randomized trial, Psilocybin was safe both physiologically and psychologically, according to Charles Grob, MD, of Harbor-UCLA Medical Center, who led the study.
The pilot study of 12 cancer patients was designed to prove that hallucinogenic drugs could be studied safely as a way to relieve the distress of advanced cancer. The study participants were given clear capsules either of active psilocybin (in a dose of 0.2 milligrams per kilogram) or a placebo (niacin, 250 milligrams) in random order. The participants’ heart rate, blood pressure and temperature were supervised during each treatment. They were also assessed for levels of depression, anxiety and mood.
The two experimental sessions occurred several weeks apart, where Dr. Grob is a professor of psychiatry. The research volunteers were monitored for the six hours following their dose. The participants were asked to lie in bed, wear a blindfold and listen to music during the first few hours following taking the medication or the placebo. They were interviewed after the six-hour session and over the next six months to assess the outcome of the treatment.
This new research brings life back in to an interesting field of research the started in the 950s and ended 1970s.
FAST,EASY,AND HASSLE FREE!!…
YOU CAN FEEL SAFE SHOPPING FROM HOME ON THIS REVIEW SITE!…